Maroon Venture Fund I LP is a highly differentiated US Venture-Growth Fund investing anchor capital in innovative early-stage ventures (Seed to Series A+) to advance Healthy Aging & Longevity by closing material innovation and funding gaps in proactive/personalised, Preventative Healthcare for the early diagnosis and reduction in chronic Population Health conditions, as well as, direct Climate Impact on Health.
Only 4% of Healthcare investment is invested in Preventative & Public Health, despite the fact that the US ranks 60th globally in life expectancy and also represents 64% of global pharma profits. Chronic Population Health conditions impact 50% of the US population and drive 80% of healthcare costs.
Only 2% of Climate finance is invested in Climate-Health related areas, and although the Built Environment represents 50% of our global carbon footprint it is only 4% of Climate investment.